Kier has signed a Pre-Construction Services Agreement (PCSA) with Haleon to deliver a state-of-the-art global Oral Health Innovation hub in Weybridge, Surrey.
Named by the UK Government as part of its International Investment Summit, it’s a key space to support research and development for the global health provider, with brands including Sensodyne, Centrum and Panadol. The four-storey building is set to be a centre of global excellence for oral health life sciences research and innovation when complete.
Representatives from Kier joined Haleon today for a groundbreaking ceremony attended by Baroness Jones of Whitchurch, the UK Minister for Technology.
The new space will incorporate state-of-the-art and digitally enabled laboratories, alongside contemporary office workspaces and a dedicated consumer behavioural research facility. Equipped with the latest technology, the centre will feature a cutting-edge digital immersive room that will bridge the gap between ideas and reality, connecting the hub to Haleon’s manufacturing site in Levice, Slovakia.
The scheme will also feature a new car park building with 50% allocation for EV charging spaces, and site-wide landscaping and living roofs to enhance biodiversity.
